Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-mediated Rejection”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Testing effectiveness (Phase 2)Study completedNCT01873157
What this trial is testing

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Who this might be right for
Late Rejection of Renal TransplantAntibody-mediated Rejection
Medical University of Vienna 44
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Early research (Phase 1)Looking for participantsNCT06948097
What this trial is testing

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

Who this might be right for
Lung Transplantation
National Heart, Lung, and Blood Institute (NHLBI) 30
Large-scale testing (Phase 3)Ended earlyNCT02547220
What this trial is testing

Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Who this might be right for
Acute Antibody-Mediated Rejection (AMR)
Shire 39
Not applicableActive Not RecruitingNCT05184426
What this trial is testing

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)

Who this might be right for
Transplant FailureHeart Transplant RejectionAntibody-mediated Rejection
Juan Francisco Delgado Jimenez 90
Testing effectiveness (Phase 2)Study completedNCT02201576
What this trial is testing

Bortezomib in Rejection of Kidney Transplants

Who this might be right for
Chronic Antibody-mediated Transplant Rejection
Assistance Publique - Hôpitaux de Paris 60
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Not applicableStudy completedNCT03393793
What this trial is testing

HEart trAnsplantation Registry of piTie-Salpetriere University Hospital

Who this might be right for
Cardiac Transplant DisorderCardiac DeathHeart Failure+5 more
Lee S Nguyen 566
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Very early researchWithdrawnNCT05862766
What this trial is testing

Isatuximab in Lung Transplant Recipients

Who this might be right for
Antibody-mediated RejectionAllosensitization
NYU Langone Health
Not applicableUnknownNCT03430414
What this trial is testing

Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response

Who this might be right for
Antibody-mediated Rejection
Thomas Mueller 50
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableStudy completedNCT07700563
What this trial is testing

Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies

Who this might be right for
Kidney TransplantRejection of Renal TransplantAntibody Mediated Rejection+4 more
Paris Translational Research Center for Organ Transplantation 2,410
Not applicableStudy completedNCT03474536
What this trial is testing

Quantitative Parameters of HLA-DQ Antibodies in Lung Transplantation

Who this might be right for
Lung TransplantationAntibody Mediated RejectionChronic Lung Allograft Dysfunction
University Hospital, Bordeaux 88
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT04204980
What this trial is testing

Desensitization in Kidney Allograft Using Daratumumab

Who this might be right for
AllosensitizationKidney Transplant RejectionAntibody-mediated Rejection
Assistance Publique - Hôpitaux de Paris 21
Large-scale testing (Phase 3)Enrolling By InvitationNCT07444489
What this trial is testing

Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)

Who this might be right for
Antibody-mediated RejectionMicrovascular Inflammation
Biogen 201
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613359
What this trial is testing

Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant

Who this might be right for
Antibody-Mediated Rejection (AMR)
Takeda 36
Next Page